Clinical trialNCT01114724CompletedInterventional

Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections

SponsorMedtronic CardiovascularEnrollment50Aortic Dissection

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine if the Valiant stent graft is safe and effective in treating patients who have a thoracic dissection. A thoracic dissection is a tear in the wall of the aorta, that causes blood to flow between the layers of the aorta and force the layers apart (dissect). This condition is a medical emergency and can quickly lead to death. Since stent grafting has been an effective way to treat other aortic conditions such as aneurysms (bulge in aorta wall), it is believed that the device would be effective in treating dissections. Information will be collected on the performance of the device for 5 years.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Joseph E. Bavaria, M.D.
Univ. of Pennsylvania Health System
Principal Investigator
clinicaltrials.gov ↗
W. Anthony Lee, M.D., F.A.C.S
Lynn Heart Institute, Boca Raton Community Hospital
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Cedars Sinai Medical Center
Los Angeles, California, United States
Usc Keck School of Medicine
Los Angeles, California, United States
Harbor Ucla
Torrance, California, United States
Washington Hospital D.C.
Washington D.C., District of Columbia, United States
University of Florida
Gainesville, Florida, United States
Northwestern Memorial
Chicago, Illinois, United States
University of Michigan
Ann Arbor, Michigan, United States
New York Presbyterian Weill Cornell
New York, New York, United States
Novant Health Heart and Vascular Institute
Charlotte, North Carolina, United States
Duke University Medical Center
Durham, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Vanderbilt Medical Center
Nashville, Tennessee, United States
Heart Hospital Medical Center
Dallas, Texas, United States
Baylor
Houston, Texas, United States
Memorial Hermann Heart and Vascular Institute
Houston, Texas, United States
St. Luke'S Episcopal Hospital
Houston, Texas, United States
Virginia Commonwealth University Mcv Richmond
Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 May 2010
Primary completion: 31 May 2013
Completion: 31 Oct 2017
Last update posted: 29 Oct 2021
Registered enrollment: 50
Registry id: NCT01114724

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.